Multiple Sclerosis (MS): Nursing Study Guide

Multiple sclerosis (MS) is a high-yield neurologic topic for nursing exams. This note reviews the disease process, classic signs (including Lhermitte's sign and Uhthoff's phenomenon), diagnostic findings, key medications, and priority nursing interventions.

What Is Multiple Sclerosis?

• Multiple sclerosis (MS) is a chronic, progressive autoimmune disease of the central nervous system (CNS) only — it does not involve peripheral nerves.
• Characterized by demyelination of the protective myelin sheath covering nerve fibers in the brain, spinal cord, and optic nerves.
• Demyelination disrupts nerve impulse transmission, producing a wide range of neurologic deficits.

Pathophysiology

• The immune system mistakenly attacks the myelin sheath surrounding nerve fibers.
• This attack causes inflammation and damage, resulting in scar tissue called sclerosis or plaque.
• The location of plaques determines which body functions are affected.

Types of Multiple Sclerosis

Signs and Symptoms

Motor

• Muscle weakness, especially in the legs
• Spasticity (increased muscle tone and stiffness)
• Ataxia (loss of coordination)
• Difficulty walking and maintaining balance

Sensory

• Numbness, tingling, or paresthesias
• Lhermitte's sign — an electric shock sensation down the spine when the neck is flexed forward

Visual

• Optic neuritis — painful vision loss in one eye
• Blurred or double vision

Other

• Fatigue — the most common symptom of MS
• Bladder dysfunction: urgency, frequency, incontinence
• Bowel dysfunction: constipation
• Cognitive impairment: memory loss, difficulty concentrating
• Depression
• Uhthoff's phenomenon — worsening of symptoms with heat exposure

Diagnostic Tests

Medications for Acute Relapse

• Methylprednisolone IV in high doses for 3–5 days to treat an acute relapse.
• Corticosteroids reduce inflammation and shorten relapse duration.
• Corticosteroids do not slow disease progression.
• Monitor blood glucose, potassium, blood pressure, and mood during therapy.

Disease-Modifying Therapies (DMTs)

• Interferon beta-1a and beta-1b: cause flu-like symptoms and injection site reactions; monitor liver function tests.
• Glatiramer acetate (Copaxone): causes injection site reactions; no routine lab monitoring required.
• Monoclonal antibodies (e.g., natalizumab, ocrelizumab): risk of progressive multifocal leukoencephalopathy (PML) — a rare but fatal brain infection.
• DMTs reduce relapse rates and slow disability progression but are not used during acute relapses.

Symptom Management Medications

Nursing Assessment

• Assess muscle strength, gait, and coordination.
• Check for spasticity and contractures.
• Evaluate sensory function (numbness, tingling).
• Assess vision for blurring, diplopia, or vision loss.
• Test for Lhermitte's sign by asking the patient to flex the neck forward.
• Assess bladder and bowel function.
• Screen for cognitive changes and depression.
• Ask if heat worsens symptoms (Uhthoff's phenomenon).

Nursing Interventions

• Encourage physical therapy to maintain muscle strength.
• Provide assistive devices (cane, walker, wheelchair) as needed.
• Remove tripping hazards; install handrails.
• Teach energy conservation techniques and plan rest periods.
• Never stop baclofen abruptly — taper to avoid seizures.
• Perform passive ROM to prevent contractures.
• Establish a scheduled voiding routine for bladder dysfunction.
• Encourage adequate fluids and increase fiber for constipation.
• Avoid extreme heat, which worsens symptoms.
• Report signs of infection — infections can trigger relapses.

Common Exam Traps

• Lhermitte's sign = electric shock down the spine with neck flexion.
• Uhthoff's phenomenon = symptoms worsen with heat.
• Optic neuritis = painful, unilateral vision loss.
• MRI shows white matter lesions; oligoclonal bands in CSF support diagnosis.
• Corticosteroids treat acute relapses but do not slow progression.
• DMTs reduce relapse rates but are not used in acute relapses.
• Baclofen withdrawal can cause seizures — do not stop abruptly.
• Natalizumab carries a risk of PML.

Key takeaways

• MS is a chronic autoimmune demyelinating disease of the CNS; RRMS is the most common type.
• Fatigue is the most common symptom; classic findings include Lhermitte's sign, Uhthoff's phenomenon, and optic neuritis.
• MRI (white matter lesions) and CSF oligoclonal bands are key diagnostics.
• IV methylprednisolone treats acute relapses; DMTs reduce relapse rates and slow progression but are not used in acute attacks.
• Never stop baclofen abruptly — withdrawal can cause seizures.
• Nursing priorities: manage spasticity, fatigue, and bladder dysfunction; prevent falls; and avoid heat exposure and infections that can trigger relapses.